Telesis Bio, Inc.
TBIO · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$47,724 | -$48,471 | -$38,958 | -$18,010 |
| Dep. & Amort. | $4,102 | $2,875 | $1,574 | $1,457 |
| Deferred Tax | $0 | $0 | $2,304 | $443 |
| Stock-Based Comp. | $3,963 | $3,727 | $1,086 | $43 |
| Change in WC | -$7,766 | $2,130 | -$3,037 | -$20 |
| Other Non-Cash | $12,758 | $1,024 | $333 | $706 |
| Operating Cash Flow | -$34,667 | -$38,715 | -$36,698 | -$15,381 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,980 | -$4,468 | -$1,854 | -$204 |
| Net Acquisitions | $16 | -$556 | -$13,186 | $0 |
| Inv. Purchases | -$33,775 | -$77,428 | $0 | $0 |
| Inv. Sales/Matur. | $29,995 | $64,445 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$5,744 | -$18,007 | -$15,040 | -$204 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$15,092 | $4,682 | $9,791 | -$107 |
| Stock Issued | $26,657 | $528 | $112,484 | $11 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $26,657 | -$700 | -$1,194 | $0 |
| Financing Cash Flow | $11,565 | $4,510 | $121,081 | -$96 |
| Forex Effect | -$3 | $0 | $0 | $0 |
| Net Chg. in Cash | -$28,849 | -$52,212 | $69,343 | -$15,681 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $30,594 | $82,806 | $13,463 | $29,144 |
| End Cash | $1,745 | $30,594 | $82,806 | $13,463 |
| Free Cash Flow | -$36,647 | -$43,183 | -$38,552 | -$15,585 |